Abstract

BackgroundDEPTOR is an endogenous inhibitor of mTORC1 and mTORC2 that plays a vital role in the progression of human malignances. However, the biological function of DEPTOR in HCC metastasis and the underlying molecular mechanisms are still unclear.MethodsWestern blot analysis and immunohistochemistry(IHC) were employed to examine DEPTOR expression in HCC cell lines and tissues. A series of in vivo and in vitro assays were performed to determine the function of DEPTOR and the possible mechanisms underlying its role in HCC metastasis.ResultsWe found that DEPTOR was frequently overexpressed in HCC tissues, and its high expression was associated with high serum AFP levels, increased tumor size, vascular invasion and more advanced TMN and BCLC stage, as well as an overall poor prognosis. Functional experiments demonstrated that DEPTOR silencing inhibited the proliferation and mobility of HCC cells in vitro and suppressed tumor growth and metastasis of HCC cells in vivo. Accordingly, DEPTOR overexpression promoted the invasion and metastasis of HCC cells in vitro and in vivo, but had no effect on cell proliferation in vitro. Overexpression of DEPTOR induced EMT by snail induction. Conversely, knockdown of snail expression impaired the DEPTOR-induced migration, invasion and EMT of HCC cells. Furthermore, we found that the increase of snail expression by DEPTOR overexpression was due to an activation of TGF-β1-smad3/smad4 signaling possibly through feedback inhibition of mTOR.ConclusionDEPTOR promotes the EMT and metastasis of HCC cells by activating the TGF-β1-smad3/smad4-snail pathway via mTOR inhibition. Therefore, targeting DEPTOR may be an ideal treatment strategy for inhibiting the growth and metastasis of HCC.

Highlights

  • Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor and the third leading cause of cancer-related mortality worldwide [1, 2]

  • DEP domain containing mTOR interacting protein (DEPTOR) was highly expressed in HCC To explore the possible role of DEPTOR in HCC, we first detected its expression in a tissue microarray of 110 pairs of HCC and adjacent non-tumor tissues by IHC staining

  • The IHC assays showed that DEPTOR was overexpressed in 60% (66/110) of HCC tissues and presented low expression in 40% (44/110) of HCC tissues compared with adjacent non-tumor tissues

Read more

Summary

Introduction

Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor and the third leading cause of cancer-related mortality worldwide [1, 2]. There is an urgent need to uncover new molecular mechanisms underlying HCC metastasis, and thereby enable the development of new diagnostic and therapeutic strategies to prevent and treat metastases. Epithelial-to-mesenchymal transition (EMT) plays a critical role in embryonic development, would healing, fibrosis and cancer metastasis [6]. The loss of E-cadherin (encoded by CDH1) is one of the most important hallmarks of EMT, and was demonstrated to be essential for tumor invasion [9, 10]. The biological function of DEPTOR in HCC metastasis and the underlying molecular mechanisms are still unclear

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call